Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Regen BioPharma (RGBP) Shares Outstanding (2016 - 2025)

Regen BioPharma (RGBP) has disclosed Shares Outstanding for 13 consecutive years, with $34.0 as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding fell 99.88% to $34.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $34.0, a 99.88% decrease, with the full-year FY2025 number at $15007.0, down 48.85% from a year prior.
  • Shares Outstanding was $34.0 for Q4 2025 at Regen BioPharma, down from $29338.0 in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $3.8 billion in Q2 2021 to a low of $7.0 in Q3 2022.
  • A 5-year average of $215.9 million and a median of $409551.0 in 2023 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: crashed 100.0% in 2022, then soared 48305128.57% in 2023.
  • Regen BioPharma's Shares Outstanding stood at $3.0 million in 2021, then crashed by 99.04% to $29338.0 in 2022, then crashed by 48.85% to $15007.0 in 2023, then soared by 95.5% to $29338.0 in 2024, then tumbled by 99.88% to $34.0 in 2025.
  • Per Business Quant, the three most recent readings for RGBP's Shares Outstanding are $34.0 (Q4 2025), $15007.0 (Q3 2025), and $29338.0 (Q2 2025).